India Exchange Filings

Alkem Laboratories Q2FY27 Earnings Summary

Alkem Laboratories Ltd approves Q2FY27 results with revenue of ₹4,552 crore, up 13.8% YoY

  • Consolidated EBITDA was ₹1,025 crore, up 11.3% YoY; EBITDA margin was 22.5%.
  • Net profit after non-controlling interest was ₹675 crore, down 11.7% YoY.
  • Results included a ₹35 crore exceptional recovery; Occlutech was consolidated after Alkem acquired a 55% stake.
  • Auditors issued unmodified limited-review conclusions.

Original Filing

This is an automated summary of a public document. Always check the original before relying on it.